Teishima, J. (2020) “Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors”, Canadian Urological Association Journal, 14(11), pp. E582–7. doi: 10.5489/cuaj.6413.